Global  

Coronavirus vaccine safe in early trial; hydroxychloroquine may increase death risk

Reuters Friday, 22 May 2020 ()
The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
0
shares
ShareTweetSavePostSend
 
Credit: Wochit - Published
News video: Coronavirus Vaccine From China Is Safe In Early Trial

Coronavirus Vaccine From China Is Safe In Early Trial 00:40

A coronavirus vaccine developed by CanSino Biologics Inc appears to be safe. It induced a rapid immune response in its first human trial, Reuters reports. This vaccine did not cause any serious adverse effects, though side effects such as fever were noted. Blood samples from the 108 vaccinated...

You Might Like


Related videos from verified sources

Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death [Video]

Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death

Business Insider reports that a coronavirus vaccine my not be ready until the end of 2021, according to Roche, the world's second-largest pharmaceutical company. He explained "According to the most..

Credit: Wochit     Duration: 00:26Published
Publishers Can Avert Keyword Blocking: IAS’ Johnson [Video]

Publishers Can Avert Keyword Blocking: IAS’ Johnson

The COVID-19 pandemic has been extremely difficult for publishers, with many advertising buyers using keyword blocking tools to swerve virus-related stories, or simply stopping advertising in news..

Credit: BeetTV - Affiliate     Duration: 09:43Published

Tweets about this